Schmitz R, Kansy M, Moser K H, Treckmann J
Department of Surgery, Evangelisches Krankenhaus/Academic Hospital, Bergisch Gladbach, Germany.
World J Surg. 1995 May-Jun;19(3):416-8; discussion 419. doi: 10.1007/BF00299176.
A randomized prospective study of low-dose heparin was performed in 89 surgical patients during and after Bassini-Lotheissen repair. The patients were divided into two groups: (1) Low-dose heparin: 5000 units 2 hours before operation and 5000 units every 8 hours for 5 days after the operation. (2) Dextran 40 (Rheomacrodex); administered during the operation, with an additional infusion of dextran (500 ml/day) for the next 3 days. The frequency of wound complications in 45 the heparin-treated patients was 22.0% (comprising 10 hematomas), compared to only 4.5% in the dextran-treated patients (n = 44 patients). These findings are significant (p < 0.05). Low-dose heparin should therefore be administered routinely only to patients with increased risk of thromboembolism.